Microbial cancer immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity
A. W. Daman, A. C. Antonelli, G. Redelman-Sidi, L. Paddock, J. G. Cheong, L. F. Jurado, A. Benjamin, S. Jiang, D. Ahimovic, S. Khayat, M. J. Bale, O. Loutochin, V. A. McPherson, D. Pe'er, M. Divangahi, , M. Glickman
This study shows that bladder BCG immunotherapy reprograms hematopoietic stem cells to enhance anti-tumor immunity in mice and humans.
bioRxiv · Mar 21, 2024 · PreprintImmunology